eko.ai Pte. Ltd. d/b/a Us2.ai
About eko.ai Pte. Ltd. d/b/a Us2.ai
Us2.ai, formerly known as eko.ai Pte. Ltd., is a Singapore-based medtech company specializing in AI-powered solutions for echocardiography analysis. The company’s core offering is a machine learning platform that automates the often slow and manual process of analyzing echocardiograms. This technology aims to provide healthcare providers worldwide with faster, more accurate, and expert-level cardiac diagnostics, ultimately democratizing access to crucial heart health assessments.
For physicians, Us2.ai’s platform, including its flagship product Echo Copilot, offers fully automated analysis of echocardiographic studies, encompassing both 2D and Doppler images from various vendors. The software processes these images in minutes, generating comprehensive echo reports that include measurements, disease detection, and clinical findings for every heart chamber. This automation significantly reduces the manual workload for sonographers and cardiologists, allowing them to focus on critical thinking and patient care. The platform is FDA-cleared and CE-marked, with regulatory approvals in over 28 countries, and integrates seamlessly into existing clinical workflows, PACS, CVIS, and reporting systems.
The Us2.ai algorithm is designed to detect a wide array of heart-related conditions, such as heart failure (including HFrEF, HFmrEF, and HFpEF), cardiac amyloidosis, aortic stenosis, and pulmonary hypertension, aligning with international guidelines. It provides automated measurements for chamber dimensions, systolic and diastolic function, global and regional strain, and aortic stenosis metrics. The company’s mission is to improve patient outcomes and expand healthcare access by making high-quality, consistent, and affordable echo analysis available globally, addressing challenges like sonographer shortages and the complexity of echo interpretation.
Focus Areas
Business Intelligence
| Technology | Deep learning solutions, AI-powered, cloud-native, integrates with ultrasound devices and PACS, automated pattern recognition, guideline-based measurements, DICOM processing, real-time analysis |
What Physicians Need to Know
Us2.ai's fully automated echocardiogram analysis can significantly reduce reporting time and measurement variability, allowing physicians to focus on critical thinking and patient care. The vendor-neutral and DICOM-native nature of the platform ensures seamless integration into existing workflows, regardless of ultrasound machine or PACS vendor. The AI-powered disease detection for conditions like cardiac amyloidosis and heart failure can aid in earlier diagnosis and improved clinical decision-making. Physicians retain final sign-off, as the system provides a pre-populated, fully editable draft report.
Us2.ai is vendor-neutral and DICOM-native, offering flexible integration pathways. It can be deployed bundled with ultrasound systems from OEM partners (e.g., Fujifilm, GE HealthCare, Canon Medical Systems), through AI marketplaces (e.g., Viz.ai), directly into cardiology PACS or reporting systems (supporting DICOM-SR, HL7, and PDF return), or via cloud and API for research and core-lab use. It integrates with any PACS, CVIS, or EMR via standard DICOM routing, with both cloud and on-premise deployment options. Partnerships include major players like Merge Cardio, allowing for seamless integration within existing cardiovascular imaging solutions.
Products by eko.ai Pte. Ltd. d/b/a Us2.ai
What the Web Says
Us2.ai (eko.ai Pte. Ltd. d/b/a Us2.ai) is a healthcare AI company specializing in cardiology AI tools, particularly for echocardiogram analysis. Their platform aims to automate the full workflow of echo analysis, from DICOM input to structured report output, with the goal of improving efficiency, accuracy, and accessibility in cardiac care. The company has received positive feedback from cardiologists and sonographers regarding improvements in measurement accuracy and workflow efficiency. Us2.ai's products are FDA-cleared and available in over 28 markets.
Overall: PositiveStrengths
- Fully automated echocardiogram analysis, including measurements, disease detection, and structured reports.
- Significant time savings for technicians and cardiologists, reducing analysis and reporting time.
- Enhances measurement accuracy and consistency, reducing variability between sonographers.
- Addresses the shortage of cardiac sonographers and increasing demand for echo exams.
- Reduces repetitive stress injuries for sonographers by minimizing manual measurements.
- Vendor-neutral and integrates with existing PACS, CVIS, and EMR systems.
Limitations
- No specific cons were identified in the provided search results.
- No detailed employer reviews from Glassdoor or Capterra were found.
- No specific product reviews from G2 or Capterra were found.
- No Reddit discussions or reviews were found.
Based on reviews from: physicianaitools.com, deel.com, us2.ai, theimagingwire.com, indeed.com, fda.gov, fda.report, healthcareaiops.com, slashdot.org, parikhradiology.com
Last updated: 2026-10-29
Videos
News, demos, and interviews about eko.ai Pte. Ltd. d/b/a Us2.ai.
Videos load interactively. If none appear, search YouTube for eko.ai Pte. Ltd. d/b/a Us2.ai →
Press & Coverage
Frequently Asked Questions
Related Companies
OrthoAI is an innovative AI-powered platform designed to assist orthopedic surgeons in clinical decision-making, surgical planning, and patient care. It functions as a 24/7 surgical companion, providing evidence-based answers to complex clinical questions, surgical techniques, and theoretical queries. The platform leverages a meticulously curated database developed by expert orthopedic surgeons, integrates with PubMed for the […]
NuvoAir is a digital health company that provides a value-based specialty care platform focused on proactive, continuous virtual care for individuals with heart and lung conditions. The company aims to transform the diagnosis and management of chronic cardiopulmonary conditions by integrating advanced monitoring technology, data analytics, and evidence-based interventions delivered by a multidisciplinary team. NuvoAir’s […]
Infinite Biomedical Technologies, LLC (IBT) is a medical device company established in 1997 with roots at Johns Hopkins University. The company is dedicated to developing innovative solutions for individuals with upper limb loss and differences, aiming to transform laboratory research into practical medical devices. IBT focuses on advanced prosthetic control systems and related technologies to […]
The search results indicate that “Strain AI” is not a single, unified company serving physicians and healthcare providers in the traditional medical sense. Instead, the term “Strain AI” appears to be a general descriptor used by several distinct companies operating primarily in the cannabis industry, leveraging AI to recommend cannabis strains based on user preferences, […]
Samsung is a global technology leader that has significantly expanded its presence in the healthcare sector, leveraging its expertise in AI, imaging, and connected devices. The company aims to improve patient care and outcomes by providing advanced diagnostic solutions, personalized health insights, and integrated digital health platforms. Samsung’s healthcare initiatives focus on bridging the gap […]
Philips (Cardiologs) is a healthcare AI company that specializes in transforming cardiac diagnostics through medical-grade artificial intelligence and cloud technology. Their core offering is the Cardiologs Holter platform, which utilizes deep neural networks to analyze continuous ambulatory ECGs. This platform is designed to streamline ECG analysis, reduce reporting errors, and accelerate diagnostic reporting, ultimately empowering […]